IL1B and COVID-19: This means that the body avoids a prolonged inflammatory response and its damaging effects since it is known that there is increased expression of pro-inflammatory cytokines IL–1β, IL–6, TNF, IL–12, IFN–β, IFN–γ, IL–17 in COVID-19 [25].